Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Immunopharmacology

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.intimp.2014.05.004PMID 24836681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D3 Induces IDO+ Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE

  2013cited by this paper
• Tacrolimus treatment increases bone formation in patients with rheumatoid arthritis

  2013cited by this paper
• Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis

  2013cited by this paper
• IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.

  2011cited by this paper
• Tacrolimus-induced pulmonary injury in rheumatoid arthritis patients.

  2011cited by this paper
• Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses.

  2010cited by this paper
• Tacrolimus Modulates Dendritic Cell Activation in the Sensitization Phase of Allergic Contact Dermatitis

  2010cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cited by this paper
• EULAR (欧州リウマチ学会) 合成および疾患修飾性抗リウマチ生物学的製剤による関節リウマチ管理に関する推奨ガイドライン | 文献情報 | J-GLOBAL 科学技術総合リンクセンター

  2010cited by this paper
• IL-10/TGF-β-Treated Dendritic Cells, Pulsed with Insulin, Specifically Reduce the Response to Insulin of CD4+ Effector/Memory T Cells from Type 1 Diabetic Individuals

  2010cited by this paper
• Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1

  2009cited by this paper
• TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program1

  2009cited by this paper
• Biologics for rheumatoid arthritis: an overview of Cochrane reviews

  2009cited by this paper
• Effect of tacrolimus on maturity and allostimulatory activity of cultured dendritic cells of rats in vitro

  2009cited by this paper
• Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T-cell responses in rheumatoid arthritis and osteoarthritis

  2009cited by this paper
• Single center prospective study of tacrolimus efficacy and safety in treatment of rheumatoid arthritis

  2009cited by this paper
• Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study

  2009cited by this paper
• Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.

  2009cited by this paper
• Semi‐mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen‐induced arthritis mice

  2009cited by this paper
• Phase I to II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses.

  2009cited by this paper
• Tolerogenic dendritic cells for autoimmune disease and transplantation

  2008cited by this paper
• Dendritic Cells Genetically Engineered to Express IL-10 Induce Long-Lasting Antigen-Specific Tolerance in Experimental Asthma1

  2008cited by this paper
• Tolerogenic dendritic cells and the quest for transplant tolerance

  2007cited by this paper
• Immunomodulatory Dendritic Cells Inhibit Th1 Responses and Arthritis via Different Mechanisms1

  2007cited by this paper
• 1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells1

  2007cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• Interleukin‐10‐Modulated Immature Dendritic Cells Control the Proinflammatory Environment in Multiple Sclerosis

  2004cited by this paper
• Efficacy and safety of tacrolimus (FK506) in treatment of rheumatoid arthritis: a randomized, double blind, placebo controlled dose-finding study.

  2004cited by this paper
• Dendritic cells: emerging pharmacological targets of immunosuppressive drugs

  2004cited by this paper
• Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

  2004cited by this paper
• Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1

  2003cited by this paper
• Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells.

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• FK506 in the maturation of dendritic cells.

  2002cited by this paper
• Contrasting Impacts of Immunosuppressive Agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on Bidirectional Dendritic Cell-T Cell Interaction During Antigen Presentation1

  2002cited by this paper
• CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.

  2002cited by this paper
• Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

  2001cited by this paper
• Effective Treatment of Established Murine Collagen-Induced Arthritis by Systemic Administration of Dendritic Cells Genetically Modified to Express IL-41

  2001cited by this paper
• The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells

  2000cited by this paper
• FK506, an immunosuppressant targeting calcineurin function.

  2000cited by this paper
• Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses

  2000cited by this paper
• The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells.

  2000cited by this paper
• TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.

  1999cited by this paper
• Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice.

  1997cited by this paper

• Dendritic Cells: Origin, Classification, Development, Biological Functions, and Therapeutic Potential

  2025cites this paper
• Impacts of tacrolimus and glucocorticoids on peripheral blood T and B lymphocyte subsets in myasthenia gravis

  2025cites this paper
• From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis

  2025cites this paper
• Tolerogenic dendritic cells in radiation-induced lung injury

  2024cites this paper
• A comprehensive overview of tolerogenic vaccine adjuvants and their modes of action

  2024cites this paper
• Dendritic Cells: A Bridge between Tolerance Induction and Cancer Development in Transplantation Setting

  2024cites this paper
• Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration

  2023influential citation
• Cell Communication‐Mediated Selective Drug Delivery for Epitope‐Specific Deletion of Alloreactive T Cells in Organ Transplant

  2023cites this paper
• Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells

  2022cites this paper
• T cell abnormalities in systemic sclerosis.

  2022cites this paper
• Plasticity of Treg and imbalance of Treg/Th17 cells in patients with systemic sclerosis modified by FK506

  2021cites this paper
• Weiterentwicklung in der Therapie rheumatischer Erkrankungen bei Kindern und Jugendlichen

  2021cites this paper
• De Novo Carcinoma after Solid Organ Transplantation to Give Insight into Carcinogenesis in General—A Systematic Review and Meta-Analysis

  2021cites this paper
• Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology

  2020cites this paper
• DiR-labeled tolerogenic dendritic cells for targeted imaging in collagen- induced arthritis rats.

  2020cites this paper
• Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.

  2020cites this paper
• GdX/UBL4A‐knockout mice resist collagen‐induced arthritis by balancing the population of Th1/Th17 and regulatory T cells

  2019cites this paper
• Tacrolimus treatment for infertility related to maternal‐fetal immune interactions

  2019cites this paper
• STAT3 Activation in Combination with NF-KappaB Inhibition Induces Tolerogenic Dendritic Cells with High Therapeutic Potential to Attenuate Collagen-Induced Arthritis

  2019cites this paper
• Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17/Regulatory T Cell Balance

  2019cites this paper
• Bone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications

  2018cites this paper
• Efficacy and safety of tacrolimus in systemic lupus erythematosus patients with refractory thrombocytopenia: a retrospective study

  2018cites this paper
• Tacrolimus: An updated review on delivering strategies for multifarious diseases

  2018cites this paper
• Future therapeutic targets in rheumatoid arthritis?

  2017cites this paper
• Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response.

  2017cites this paper
• Modified IL-10-expressing dendritic cells ameliorate TNBS-induced Crohn's disease in mice

  2017cites this paper
• Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.

  2017cites this paper
• Tolerogenic dendritic cell therapy in organ transplantation

  2017cites this paper
• Further exploring the feasibility of dendritic cells-targeted biomimetic Texosomes as a therapeutic and preventive tumor-vaccine

  2017cites this paper
• Sniping the scout: Targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases.

  2016cites this paper
• Co-Delivery of Immunomodulators and Autoantigen as Antigen-Specific Immunotherapy for the Treatment of a Murine Model of Multiple Sclerosis

  2016cites this paper
• Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside

  2016cites this paper
• Follistatin‐like protein 1 contributes to dendritic cell and T‐lymphocyte activation in nasopharyngeal carcinoma patients by altering nuclear factor κb and Jun N‐terminal kinase expression

  2016cites this paper
• Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance

  2016cites this paper
• Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.

  2015cites this paper
• Dendritic Cell-Specific Deletion of β-Catenin Results in Fewer Regulatory T-Cells without Exacerbating Autoimmune Collagen-Induced Arthritis

  2015cites this paper
• Targeting Dendritic Cell Function during Systemic Autoimmunity to Restore Tolerance

  2014influential citation